Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Aug;61(4):422-5.
doi: 10.1007/s13224-011-0066-z. Epub 2011 Sep 28.

Implanon: subdermal single rod contraceptive implant

Pushpa Bhatia  1 , Sangita Nangia, Shivani Aggarwal, Chitra Tewari
Affiliations

Implanon: subdermal single rod contraceptive implant

Pushpa Bhatia et al. J Obstet Gynaecol India. 2011 Aug.

Abstract

Objectives: Study was conducted to determine acceptability, efficacy, safety, return of fertility with Implanon.

Methods: Volunteers having regular menstruation, requiring spacing formed study population. Implanon was inserted within 5 days of LMP or concurrent with MTP. Woman was asked to record bleeding pattern, side effects. Implanon duration was 3 years but Implanon was removed before, if patient wanted pregnancy/for side effects. Subjects who did not adopt family planning method after removal were followed up for return of ovulation and pregnancy.

Results: 200 subjects were enrolled (160 within 5 days of LMP, 40 concurrent with MTP). 74 implanon removals were done. (16 after tenure completion, 58 for other reasons.) 16% cases discontinued implanon for polymenorrhagia, 10% for irregular bleeding, 4.5% for amenorrhea. There was no failure of implanon. 40% had return of ovulation within one month, 95.8% conceived within 12 months.

Conclusions: Implanon is safe, effective, well accepted method of contraception.

Keywords: Contraceptive; Etonogestrel; Implanon.

PubMed Disclaimer

References

    1. Merki Feld GS, Imthurn B, Seifert B. Effects of the progestagen-only contraceptive Implant Implanon((R)) on cardiovascular risk factors. Clin Endocrinol (Oxf) 2008;68(3):355–360. - PubMed
    1. Wechselberger G, Wolfram D, Pulzl P, Soelder E, Schoeller T, et al. Nerve injury caused by removal of an implantable hormonal contraceptive. Am J Obstet Gynecol. 2006;195:323–326. doi: 10.1016/j.ajog.2005.09.016. - DOI - PubMed
    1. Osman N, Dinh A, Durbert T, Goubier JN, et al. A new cause for iatrogenic lesion of the ulnar nerve at the arm: contraceptive hormonal implant. Report of two cases. Chir Main. 2005;24:181–183. doi: 10.1016/j.main.2005.04.005. - DOI - PubMed
    1. Harrrison-Woolrych M, Hill R. Unintended pregnancies with the etonogestrel implant (Implanon): a case series from postmarketing experience in Australia. Contraception. 2005;71:306–308. doi: 10.1016/j.contraception.2004.10.005. - DOI - PubMed
    1. Agrawal A, Robinson C. Spontaneous snapping of an Implanon in two halves in situ. J Fam Plann Reprod Health Care. 2003;29:238. doi: 10.1783/147118903101197881. - DOI - PubMed

LinkOut - more resources